🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial, with the aim of developing a chemotherapy-free re...
Status
Active Not Recruiting
Location
Department of Hematology X, Odense University Hospital
Start Date
2021-12-15
Trial ID
NCT05214183
Treatments Being Tested
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This is a multi-arm phase 2 study to evaluate the preliminary evidence of e...
Status
Active Not Recruiting
Location
Weill Cornell Medicine
Start Date
2019-10-11
Trial ID
NCT03863184
Treatments Being Tested
This is a single- arm, open-label, multicenter, phase II study to evaluate ...
Status
Recruiting
Location
Sun yat-sen university cancer center, Sun yat-sen university
Start Date
2025-04-14
Trial ID
NCT06846489
Treatments Being Tested
To learn if giving acalabrutinib, rituximab, and brexucabtagene autoleucel ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-11-18
Trial ID
NCT05495464
Treatments Being Tested
This is a phase II, single-arm, open-label, multicentre study of acalabruti...
Status
Active Not Recruiting
Location
The Royal Bournemouth Hospital
Start Date
2023-11-30
Trial ID
NCT05004064
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of acalabrutinib...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-11-29
Trial ID
NCT03623373
This phase II trial studies the side effects of acalabrutinib and rituximab...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04765111
Treatments Being Tested
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirto...
Status
Completed
Location
Mayo Clinic of Scottsdale
Start Date
2019-03-15
Trial ID
NCT03740529
Treatments Being Tested